A comparison of in vitro acylcarnitine profiling methods for the diagnosis of classical and variant short chain acyl-CoA dehydrogenase deficiency

Sarah P. Young, Dietrich Matern, Niels Gregersen, Robert D. Stevens, Deeksha Bali, Hui Ming Liu, Dwight D. Koeberl, David S. Millington

Research output: Contribution to journalArticle

10 Citations (Scopus)

Abstract

Background: Homozygosity and compound heterozygosity for the short chain acyl-CoA dehydrogenase (SCAD) gene sequence variants 625G→A and 511C→T are associated with ethylmalonic aciduria (EMA), a biochemical indicator of SCAD deficiency. The clinical and biochemical implications of these variants are not fully understood. The effect of these variants on the accumulation of butyrylcarnitine by fibroblasts in culture was studied. Methods: In vitro acylcarnitine profiling in fibroblasts was carried out using [U- 13C]-labeled or unlabeled palmitate in the presence of excess L-carnitine, with or without a medium chain acyl-CoA dehydrogenase (MCAD) inhibitor. Acylcarnitines were analyzed using tandem mass spectrometry. 625G/625G (wild type), 625G/625A and 625A/625A (variant) control fibroblasts were compared with fibroblasts from patients homozygous for inactivating SCAD mutations (SCAD deficient) and from patients with EMA who were homozygous or compound heterozygous for the SCAD variants. Results: Variant control and patient fibroblasts accumulated moderate amounts of butyrylcarnitine compared with wild-type controls and in contrast to the significant amount of butyrylcarnitine accumulated by SCAD deficient fibroblasts, regardless of incubation conditions. Conclusions: Moderately reduced SCAD activity associated with SCAD variants can be detected using in vitro acylcarnitine profiling methods, which may be used as an indirect measure of SCAD activity.

Original languageEnglish (US)
Pages (from-to)103-113
Number of pages11
JournalClinica Chimica Acta
Volume337
Issue number1-2
DOIs
StatePublished - Nov 2003

Fingerprint

Butyryl-CoA Dehydrogenase
Fibroblasts
Acyl-CoA Dehydrogenase
acylcarnitine
In Vitro Techniques
Short chain Acyl CoA dehydrogenase deficiency
Carnitine
Palmitates
Tandem Mass Spectrometry
Cell culture
Mass spectrometry
Genes

Keywords

  • Acylcarnitine profiling
  • Butyrylcarnitine
  • Ethylmalonic aciduria
  • Human skin fibroblasts
  • Polymorphism
  • SCAD deficiency
  • Tandem mass spectrometry

ASJC Scopus subject areas

  • Biochemistry
  • Clinical Biochemistry

Cite this

A comparison of in vitro acylcarnitine profiling methods for the diagnosis of classical and variant short chain acyl-CoA dehydrogenase deficiency. / Young, Sarah P.; Matern, Dietrich; Gregersen, Niels; Stevens, Robert D.; Bali, Deeksha; Liu, Hui Ming; Koeberl, Dwight D.; Millington, David S.

In: Clinica Chimica Acta, Vol. 337, No. 1-2, 11.2003, p. 103-113.

Research output: Contribution to journalArticle

Young, SP, Matern, D, Gregersen, N, Stevens, RD, Bali, D, Liu, HM, Koeberl, DD & Millington, DS 2003, 'A comparison of in vitro acylcarnitine profiling methods for the diagnosis of classical and variant short chain acyl-CoA dehydrogenase deficiency', Clinica Chimica Acta, vol. 337, no. 1-2, pp. 103-113. https://doi.org/10.1016/j.cccn.2003.07.006
Young, Sarah P. ; Matern, Dietrich ; Gregersen, Niels ; Stevens, Robert D. ; Bali, Deeksha ; Liu, Hui Ming ; Koeberl, Dwight D. ; Millington, David S. / A comparison of in vitro acylcarnitine profiling methods for the diagnosis of classical and variant short chain acyl-CoA dehydrogenase deficiency. In: Clinica Chimica Acta. 2003 ; Vol. 337, No. 1-2. pp. 103-113.
@article{e51ed4137ace4b0d83b8d65fffe41311,
title = "A comparison of in vitro acylcarnitine profiling methods for the diagnosis of classical and variant short chain acyl-CoA dehydrogenase deficiency",
abstract = "Background: Homozygosity and compound heterozygosity for the short chain acyl-CoA dehydrogenase (SCAD) gene sequence variants 625G→A and 511C→T are associated with ethylmalonic aciduria (EMA), a biochemical indicator of SCAD deficiency. The clinical and biochemical implications of these variants are not fully understood. The effect of these variants on the accumulation of butyrylcarnitine by fibroblasts in culture was studied. Methods: In vitro acylcarnitine profiling in fibroblasts was carried out using [U- 13C]-labeled or unlabeled palmitate in the presence of excess L-carnitine, with or without a medium chain acyl-CoA dehydrogenase (MCAD) inhibitor. Acylcarnitines were analyzed using tandem mass spectrometry. 625G/625G (wild type), 625G/625A and 625A/625A (variant) control fibroblasts were compared with fibroblasts from patients homozygous for inactivating SCAD mutations (SCAD deficient) and from patients with EMA who were homozygous or compound heterozygous for the SCAD variants. Results: Variant control and patient fibroblasts accumulated moderate amounts of butyrylcarnitine compared with wild-type controls and in contrast to the significant amount of butyrylcarnitine accumulated by SCAD deficient fibroblasts, regardless of incubation conditions. Conclusions: Moderately reduced SCAD activity associated with SCAD variants can be detected using in vitro acylcarnitine profiling methods, which may be used as an indirect measure of SCAD activity.",
keywords = "Acylcarnitine profiling, Butyrylcarnitine, Ethylmalonic aciduria, Human skin fibroblasts, Polymorphism, SCAD deficiency, Tandem mass spectrometry",
author = "Young, {Sarah P.} and Dietrich Matern and Niels Gregersen and Stevens, {Robert D.} and Deeksha Bali and Liu, {Hui Ming} and Koeberl, {Dwight D.} and Millington, {David S.}",
year = "2003",
month = "11",
doi = "10.1016/j.cccn.2003.07.006",
language = "English (US)",
volume = "337",
pages = "103--113",
journal = "Clinica Chimica Acta",
issn = "0009-8981",
publisher = "Elsevier",
number = "1-2",

}

TY - JOUR

T1 - A comparison of in vitro acylcarnitine profiling methods for the diagnosis of classical and variant short chain acyl-CoA dehydrogenase deficiency

AU - Young, Sarah P.

AU - Matern, Dietrich

AU - Gregersen, Niels

AU - Stevens, Robert D.

AU - Bali, Deeksha

AU - Liu, Hui Ming

AU - Koeberl, Dwight D.

AU - Millington, David S.

PY - 2003/11

Y1 - 2003/11

N2 - Background: Homozygosity and compound heterozygosity for the short chain acyl-CoA dehydrogenase (SCAD) gene sequence variants 625G→A and 511C→T are associated with ethylmalonic aciduria (EMA), a biochemical indicator of SCAD deficiency. The clinical and biochemical implications of these variants are not fully understood. The effect of these variants on the accumulation of butyrylcarnitine by fibroblasts in culture was studied. Methods: In vitro acylcarnitine profiling in fibroblasts was carried out using [U- 13C]-labeled or unlabeled palmitate in the presence of excess L-carnitine, with or without a medium chain acyl-CoA dehydrogenase (MCAD) inhibitor. Acylcarnitines were analyzed using tandem mass spectrometry. 625G/625G (wild type), 625G/625A and 625A/625A (variant) control fibroblasts were compared with fibroblasts from patients homozygous for inactivating SCAD mutations (SCAD deficient) and from patients with EMA who were homozygous or compound heterozygous for the SCAD variants. Results: Variant control and patient fibroblasts accumulated moderate amounts of butyrylcarnitine compared with wild-type controls and in contrast to the significant amount of butyrylcarnitine accumulated by SCAD deficient fibroblasts, regardless of incubation conditions. Conclusions: Moderately reduced SCAD activity associated with SCAD variants can be detected using in vitro acylcarnitine profiling methods, which may be used as an indirect measure of SCAD activity.

AB - Background: Homozygosity and compound heterozygosity for the short chain acyl-CoA dehydrogenase (SCAD) gene sequence variants 625G→A and 511C→T are associated with ethylmalonic aciduria (EMA), a biochemical indicator of SCAD deficiency. The clinical and biochemical implications of these variants are not fully understood. The effect of these variants on the accumulation of butyrylcarnitine by fibroblasts in culture was studied. Methods: In vitro acylcarnitine profiling in fibroblasts was carried out using [U- 13C]-labeled or unlabeled palmitate in the presence of excess L-carnitine, with or without a medium chain acyl-CoA dehydrogenase (MCAD) inhibitor. Acylcarnitines were analyzed using tandem mass spectrometry. 625G/625G (wild type), 625G/625A and 625A/625A (variant) control fibroblasts were compared with fibroblasts from patients homozygous for inactivating SCAD mutations (SCAD deficient) and from patients with EMA who were homozygous or compound heterozygous for the SCAD variants. Results: Variant control and patient fibroblasts accumulated moderate amounts of butyrylcarnitine compared with wild-type controls and in contrast to the significant amount of butyrylcarnitine accumulated by SCAD deficient fibroblasts, regardless of incubation conditions. Conclusions: Moderately reduced SCAD activity associated with SCAD variants can be detected using in vitro acylcarnitine profiling methods, which may be used as an indirect measure of SCAD activity.

KW - Acylcarnitine profiling

KW - Butyrylcarnitine

KW - Ethylmalonic aciduria

KW - Human skin fibroblasts

KW - Polymorphism

KW - SCAD deficiency

KW - Tandem mass spectrometry

UR - http://www.scopus.com/inward/record.url?scp=0142195901&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0142195901&partnerID=8YFLogxK

U2 - 10.1016/j.cccn.2003.07.006

DO - 10.1016/j.cccn.2003.07.006

M3 - Article

C2 - 14568186

AN - SCOPUS:0142195901

VL - 337

SP - 103

EP - 113

JO - Clinica Chimica Acta

JF - Clinica Chimica Acta

SN - 0009-8981

IS - 1-2

ER -